ID   TRYB2_HUMAN             Reviewed;         275 AA.
AC   P20231; D2E6S0; D2E6S2; O95827; Q15664; Q9UQI6; Q9UQI7;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   10-MAY-2017, entry version 164.
DE   RecName: Full=Tryptase beta-2;
DE            Short=Tryptase-2;
DE            EC=3.4.21.59;
DE   AltName: Full=Tryptase II;
DE   Flags: Precursor;
GN   Name=TPSB2; Synonyms=TPS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (VARIANT BETA-2).
RC   TISSUE=Lung;
RX   PubMed=2203827; DOI=10.1172/JCI114786;
RA   Miller J.S., Moxley G., Schwartz L.B.;
RT   "Cloning and characterization of a second complementary DNA for human
RT   tryptase.";
RL   J. Clin. Invest. 86:864-870(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (VARIANT BETA-2).
RX   PubMed=8434231; DOI=10.1111/j.1365-3083.1993.tb01757.x;
RA   Blom T., Hellman L.;
RT   "Characterization of a tryptase mRNA expressed in the human basophil
RT   cell line KU812.";
RL   Scand. J. Immunol. 37:203-208(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (VARIANTS BETA-2 AND BETA-3).
RX   PubMed=9920877; DOI=10.1074/jbc.274.6.3355;
RA   Pallaoro M., Fejzo M.S., Shayesteh L., Blount J.L., Caughey G.H.;
RT   "Characterization of genes encoding known and novel human mast cell
RT   tryptases on chromosome 16p13.3.";
RL   J. Biol. Chem. 274:3355-3362(1999).
RN   [4]
RP   SEQUENCE REVISION.
RA   Pallaoro M., Fejzo M.S., Shayesteh L., Blount J.L., Caughey G.H.;
RL   Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (VARIANT BETA-2), AND NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 50-275 (VARIANT BETA-3).
RX   PubMed=19748655; DOI=10.1016/j.jaci.2009.07.026;
RA   Trivedi N.N., Tamraz B., Chu C., Kwok P.Y., Caughey G.H.;
RT   "Human subjects are protected from mast cell tryptase deficiency
RT   despite frequent inheritance of loss-of-function mutations.";
RL   J. Allergy Clin. Immunol. 124:1099-1105(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (VARIANT BETA-2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-275 (VARIANT BETA-2), AND NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 9-275 (VARIANT BETA-3).
RX   PubMed=2187193; DOI=10.1073/pnas.87.10.3811;
RA   Vanderslice P., Ballinger S.M., Tam E.K., Goldstein S.M., Craik C.S.,
RA   Caughey G.H.;
RT   "Human mast cell tryptase: multiple cDNAs and genes reveal a multigene
RT   serine protease family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:3811-3815(1990).
RN   [9]
RP   FORMATION OF A COMPLEX WITH SERPINB6.
RX   PubMed=14670919; DOI=10.1182/blood-2003-08-2981;
RA   Strik M.C., Wolbink A., Wouters D., Bladergroen B.A., Verlaan A.R.,
RA   van Houdt I.S., Hijlkema S., Hack C.E., Kummer J.A.;
RT   "Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human
RT   mast cells and forms complexes with beta-tryptase monomers.";
RL   Blood 103:2710-2717(2004).
RN   [10]
RP   SUBUNIT.
RX   PubMed=18039527; DOI=10.1016/j.intimp.2007.07.007;
RA   Fukuoka Y., Schwartz L.B.;
RT   "Active monomers of human beta-tryptase have expanded substrate
RT   specificities.";
RL   Int. Immunopharmacol. 7:1900-1908(2007).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=9521329; DOI=10.1038/32703;
RA   Pereira P.J.B., Bergner A., Macedo-Ribeiro S., Huber R.,
RA   Matschiner G., Fritz H., Sommerhoff C.P., Bode W.;
RT   "Human beta-tryptase is a ring-like tetramer with active sites facing
RT   a central pore.";
RL   Nature 392:306-311(1998).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS).
RX   PubMed=10500112; DOI=10.1073/pnas.96.20.10984;
RA   Sommerhoff C.P., Bode W., Pereira P.J.B., Stubbs M.T.,
RA   Stuerzebecher J., Piechottka G.P., Matschiner G., Bergner A.;
RT   "The structure of the human betaII-tryptase tetramer: fo(u)r better or
RT   worse.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:10984-10991(1999).
CC   -!- FUNCTION: Tryptase is the major neutral protease present in mast
CC       cells and is secreted upon the coupled activation-degranulation
CC       response of this cell type. May play a role in innate immunity.
CC       {ECO:0000250, ECO:0000250|UniProtKB:P21845}.
CC   -!- CATALYTIC ACTIVITY: Preferential cleavage: Arg-|-Xaa, Lys-|-Xaa,
CC       but with more restricted specificity than trypsin.
CC   -!- SUBUNIT: Homotetramer. The active tetramer is converted to
CC       inactive monomers at neutral and acidic pH in the absence of
CC       heparin. Low concentrations of inactive monomers become active
CC       monomers at pH 6.0 in the presence of heparin. When the
CC       concentration of active monomers is higher, they convert to active
CC       monomers and then to active tetramers. These monomers are active
CC       and functionally distinct from the tetrameric enzyme. In contrast
CC       to the hidden active sites in the tetrameric form, the active site
CC       of the monomeric form is accessible for macromolecular proteins
CC       and inhibitors eg: fibrinogen which is a substrate for the
CC       monomeric but not for the tetrameric form. The monomeric form
CC       forms a complex with SERPINB6. {ECO:0000269|PubMed:18039527}.
CC   -!- SUBCELLULAR LOCATION: Secreted. Note=Released from the secretory
CC       granules upon mast cell activation.
CC   -!- POLYMORPHISM: There are two alleles; beta-II and beta-III. Beta-II
CC       is the most commun allele. There are two forms of the beta-III
CC       allele, a short and a long form. The short form (also named
CC       frameshifted form) is carried by 23% and 19% of individuals of
CC       European and African ancestry but 0% of Asian subjects. In the
CC       human genome reference version GRCh37/hg19, the allele beta-III
CC       short form is represented. {ECO:0000269|PubMed:19748655,
CC       ECO:0000269|PubMed:2187193, ECO:0000269|PubMed:2203827,
CC       ECO:0000269|PubMed:8434231, ECO:0000269|PubMed:9920877}.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. Tryptase
CC       subfamily. {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M37488; AAA51843.1; -; mRNA.
DR   EMBL; S55551; AAD13876.1; -; mRNA.
DR   EMBL; AF099143; AAD17859.2; -; Genomic_DNA.
DR   EMBL; AF099145; AAD17857.1; -; Genomic_DNA.
DR   EMBL; AF099146; AAD17858.1; -; Genomic_DNA.
DR   EMBL; FJ931117; ACZ98911.1; -; Genomic_DNA.
DR   EMBL; FJ931120; ACZ98913.1; -; mRNA.
DR   EMBL; AC120498; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC029356; AAH29356.1; -; mRNA.
DR   EMBL; M33492; AAA36779.1; -; mRNA.
DR   EMBL; M33493; AAA36780.1; -; mRNA.
DR   PIR; B35863; B35863.
DR   PIR; C35863; C35863.
DR   RefSeq; NP_003285.2; NM_003294.3.
DR   RefSeq; NP_077078.5; NM_024164.5.
DR   UniGene; Hs.405479; -.
DR   UniGene; Hs.592982; -.
DR   PDB; 1A0L; X-ray; 3.00 A; A/B/C/D=31-274.
DR   PDB; 1AAO; Model; -; A=31-275.
DR   PDB; 2BM2; X-ray; 2.20 A; A/B/C/D=31-275.
DR   PDB; 2FPZ; X-ray; 2.00 A; A/B/C/D=31-275.
DR   PDB; 2FS8; X-ray; 2.50 A; A/B/C/D=31-275.
DR   PDB; 2FS9; X-ray; 2.30 A; A/B/C/D=31-275.
DR   PDB; 2FWW; X-ray; 2.25 A; A/B/C/D=31-275.
DR   PDB; 2FXR; X-ray; 2.50 A; A/B/C/D=31-275.
DR   PDB; 2GDD; X-ray; 2.35 A; A/B/C/D=31-275.
DR   PDB; 2ZA5; X-ray; 2.30 A; A/B/C/D=31-275.
DR   PDB; 3V7T; X-ray; 2.09 A; A/B/C/D=31-275.
DR   PDBsum; 1A0L; -.
DR   PDBsum; 1AAO; -.
DR   PDBsum; 2BM2; -.
DR   PDBsum; 2FPZ; -.
DR   PDBsum; 2FS8; -.
DR   PDBsum; 2FS9; -.
DR   PDBsum; 2FWW; -.
DR   PDBsum; 2FXR; -.
DR   PDBsum; 2GDD; -.
DR   PDBsum; 2ZA5; -.
DR   PDBsum; 3V7T; -.
DR   ProteinModelPortal; P20231; -.
DR   SMR; P20231; -.
DR   BioGrid; 113029; 2.
DR   BioGrid; 122201; 15.
DR   IntAct; P20231; 2.
DR   STRING; 9606.ENSP00000343577; -.
DR   BindingDB; P20231; -.
DR   DrugBank; DB04654; 4-PIPERIDIN-4-YLBUTANAL.
DR   DrugBank; DB04764; [4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE.
DR   DrugBank; DB02018; Amido Phenyl Pyruvic Acid.
DR   MEROPS; S01.015; -.
DR   iPTMnet; P20231; -.
DR   PhosphoSitePlus; P20231; -.
DR   BioMuta; TPSB2; -.
DR   DMDM; 116242830; -.
DR   PaxDb; P20231; -.
DR   PeptideAtlas; P20231; -.
DR   PRIDE; P20231; -.
DR   DNASU; 64499; -.
DR   DNASU; 7177; -.
DR   Ensembl; ENST00000606293; ENSP00000482743; ENSG00000197253.
DR   GeneID; 64499; -.
DR   GeneID; 7177; -.
DR   KEGG; hsa:64499; -.
DR   KEGG; hsa:7177; -.
DR   UCSC; uc032dnv.1; human.
DR   CTD; 64499; -.
DR   CTD; 7177; -.
DR   DisGeNET; 64499; -.
DR   DisGeNET; 7177; -.
DR   GeneCards; TPSB2; -.
DR   HGNC; HGNC:14120; TPSB2.
DR   HPA; HPA049153; -.
DR   HPA; HPA049554; -.
DR   MIM; 191081; gene.
DR   neXtProt; NX_P20231; -.
DR   OpenTargets; ENSG00000172236; -.
DR   PharmGKB; PA36698; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   HOVERGEN; HBG013304; -.
DR   InParanoid; P20231; -.
DR   KO; K01340; -.
DR   PhylomeDB; P20231; -.
DR   BRENDA; 3.4.21.59; 2681.
DR   EvolutionaryTrace; P20231; -.
DR   GeneWiki; TPSAB1; -.
DR   GeneWiki; TPSB2; -.
DR   PRO; PR:P20231; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000172236; -.
DR   CleanEx; HS_TPSB2; -.
DR   ExpressionAtlas; P20231; baseline and differential.
DR   Genevisible; P20231; HS.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB.
DR   GO; GO:0008236; F:serine-type peptidase activity; TAS:ProtInc.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Hydrolase; Phosphoprotein; Polymorphism; Protease; Reference proteome;
KW   Secreted; Serine protease; Signal; Zymogen.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   PROPEP       19     30       Activation peptide.
FT                                /FTId=PRO_0000027481.
FT   CHAIN        31    275       Tryptase beta-2.
FT                                /FTId=PRO_0000027482.
FT   DOMAIN       31    272       Peptidase S1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00274}.
FT   ACT_SITE     74     74       Charge relay system.
FT   ACT_SITE    121    121       Charge relay system.
FT   ACT_SITE    224    224       Charge relay system.
FT   MOD_RES      97     97       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P21845}.
FT   CARBOHYD    233    233       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     59     75
FT   DISULFID    155    230
FT   DISULFID    188    211
FT   DISULFID    220    248
FT   VARIANT      51     53       HGP -> RDR (in beta-III).
FT                                /FTId=VAR_012104.
FT   CONFLICT    132    132       N -> K (in Ref. 1; AAA51843, 2; AAD13876,
FT                                3; AAD17858, 5; ACZ98911, 7; AAH29356 and
FT                                8; AAA36779/AAA36780). {ECO:0000305}.
FT   CONFLICT    141    141       T -> A (in Ref. 5; ACZ98913).
FT                                {ECO:0000305}.
FT   CONFLICT    240    240       G -> D (in Ref. 5; ACZ98913).
FT                                {ECO:0000305}.
FT   STRAND       32     36       {ECO:0000244|PDB:3V7T}.
FT   STRAND       39     41       {ECO:0000244|PDB:2BM2}.
FT   STRAND       45     50       {ECO:0000244|PDB:2FPZ}.
FT   STRAND       52     54       {ECO:0000244|PDB:2FPZ}.
FT   STRAND       56     65       {ECO:0000244|PDB:2FPZ}.
FT   STRAND       68     71       {ECO:0000244|PDB:2FPZ}.
FT   HELIX        73     76       {ECO:0000244|PDB:2FPZ}.
FT   HELIX        83     85       {ECO:0000244|PDB:2FPZ}.
FT   STRAND       86     89       {ECO:0000244|PDB:2FPZ}.
FT   TURN         95     98       {ECO:0000244|PDB:2FPZ}.
FT   STRAND      102    109       {ECO:0000244|PDB:2FPZ}.
FT   TURN        116    118       {ECO:0000244|PDB:2FPZ}.
FT   STRAND      123    129       {ECO:0000244|PDB:2FPZ}.
FT   STRAND      135    137       {ECO:0000244|PDB:2FPZ}.
FT   STRAND      154    161       {ECO:0000244|PDB:2FPZ}.
FT   STRAND      176    183       {ECO:0000244|PDB:2FPZ}.
FT   HELIX       185    193       {ECO:0000244|PDB:2FPZ}.
FT   STRAND      209    212       {ECO:0000244|PDB:2FPZ}.
FT   STRAND      215    218       {ECO:0000244|PDB:2FPZ}.
FT   TURN        221    225       {ECO:0000244|PDB:2ZA5}.
FT   STRAND      227    232       {ECO:0000244|PDB:2FPZ}.
FT   STRAND      235    244       {ECO:0000244|PDB:2FPZ}.
FT   STRAND      246    250       {ECO:0000244|PDB:2FPZ}.
FT   STRAND      255    259       {ECO:0000244|PDB:2FPZ}.
FT   HELIX       260    263       {ECO:0000244|PDB:2FPZ}.
FT   HELIX       264    267       {ECO:0000244|PDB:2FPZ}.
FT   TURN        268    270       {ECO:0000244|PDB:2FPZ}.
SQ   SEQUENCE   275 AA;  30515 MW;  ADC48FDC51F37112 CRC64;
     MLNLLLLALP VLASRAYAAP APGQALQRVG IVGGQEAPRS KWPWQVSLRV HGPYWMHFCG
     GSLIHPQWVL TAAHCVGPDV KDLAALRVQL REQHLYYQDQ LLPVSRIIVH PQFYTAQIGA
     DIALLELEEP VNVSSHVHTV TLPPASETFP PGMPCWVTGW GDVDNDERLP PPFPLKQVKV
     PIMENHICDA KYHLGAYTGD DVRIVRDDML CAGNTRRDSC QGDSGGPLVC KVNGTWLQAG
     VVSWGEGCAQ PNRPGIYTRV TYYLDWIHHY VPKKP
//
